U.S. Markets closed

Orexigen Therapeutics, Inc. (OREX)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
3.12+0.03 (+0.97%)
At close: 4:00PM EDT
People also watch
VVUSARNAKERXMNKDACHN
Full screen
Previous Close3.09
Open3.09
Bid2.12 x 100
Ask7.21 x 5000
Day's Range2.82 - 3.13
52 Week Range1.65 - 5.70
Volume201,022
Avg. Volume182,722
Market Cap47.51M
Beta2.81
PE Ratio (TTM)-0.64
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Orexigen (OREX) Down 9.4% Since Earnings Report: Can It Rebound?
    Zacks12 days ago

    Orexigen (OREX) Down 9.4% Since Earnings Report: Can It Rebound?

    Orexigen (OREX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Capital Cube20 days ago

    ETFs with exposure to Orexigen Therapeutics, Inc. : June 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Orexigen Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OREX-US. Comparing the performance and risk of Orexigen Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Orexigen Therapeutics, Inc. :OREX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
    Capital Cube23 days ago

    Orexigen Therapeutics, Inc. :OREX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Orexigen Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Orexigen Therapeutics, Inc. – Arena Pharmaceuticals, Inc., VIVUS, Inc., Zafgen, Inc., Johnson & Johnson, Lannett Company, Inc., Athersys, Inc., Boston Scientific Corporation and Bristol-Myers Squibb Company (ARNA-US, VVUS-US, ... Read more (Read more...)